Astrazeneca plc ADR (NASDAQ: AZN) is -2.55% lower on its value in year-to-date trading and has touched a low of $60.47 and a high of $87.68 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AZN stock was last observed hovering at around $64.26 in the last trading session, with the day’s gains setting it 1.37%.
Currently trading at $65.63, the stock is -2.13% and -10.64% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 6.38 million and changing 2.13% at the moment leaves the stock -12.15% off its SMA200. AZN registered 3.18% gain for a year compared to 6-month loss of -16.44%. The firm has a 50-day simple moving average (SMA 50) of $73.4438 and a 200-day simple moving average (SMA200) of $74.7032.
The stock witnessed a -13.53% gain in the last 1 month and extending the period to 3 months gives it a -24.23%, and is 3.80% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.41% over the week and 1.88% over the month.
Astrazeneca plc ADR (AZN) has around 89900 employees, a market worth around $203.49B and $51.21B in sales. Current P/E ratio is 31.54 and Fwd P/E is 13.90. Profit margin for the company is 12.68%. Distance from 52-week low is 8.53% and -25.14% from its 52-week high. The company has generated returns on investments over the last 12 months (9.19%).
with sales reaching $14.14B over the same period.The EPS is expected to grow by 13.64% this year, but quarterly earnings will post 16.32% year-over-year. Quarterly sales are estimated to grow 17.56% in year-over-year returns.
Astrazeneca plc ADR (AZN) Top Institutional Holders
1478.0 institutions hold shares in Astrazeneca plc ADR (AZN), with institutional investors hold 16.76% of the company’s shares. The shares outstanding are 3.10B, and float is at 3.10B with Short Float at 0.15%. Institutions hold 16.76% of the Float.
The top institutional shareholder in the company is PRICE T ROWE ASSOCIATES INC /MD/ with over 64.94 million shares valued at $5.06 billion. The investor’s holdings represent 2.0962% of the AZN Shares outstanding. As of 2024-06-30, the second largest holder is PRIMECAP MANAGEMENT CO/CA/ with 42.6 million shares valued at $3.32 billion to account for 1.375 of the shares outstanding. The other top investors are WELLINGTON MANAGEMENT GROUP LLP which holds 40.57 million shares representing 1.3096% and valued at over $3.16 billion, while CAPITAL INTERNATIONAL INVESTORS holds 1.1848 of the shares totaling 36.7 million with a market value of $2.86 billion.
Astrazeneca plc ADR (AZN) Insider Activity
#####
